Delineating Molecular Regulatory of Flavonoids Indicated by Transcriptomic and Metabolomics Analysis during Flower Development in Chrysanthemum morifolium ‘Boju’
International Journal of Molecular Sciences · 24.09.2024 · 25 (19) · 10261
DOI: 10.3390/ijms251910261 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.09.2024. Verfasst von Zhuannan Chu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Horticultural Crop Germplasm Innovation and Utilization (Co-Construction by Ministry and Province), Institute of Horticulture, Anhu…. Hauptthemen laut MEDLINE: Chrysanthemum, Flowers, Flavonoids, Gene Expression Regulation, Plant. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Agriculture Research System, Joint Research Center for Chinese Herbal Medicine of Anhui of IHM Project.
Abstract (Originalsprache)
Flavonoids are pharmacologically active compounds in flowers of Chrysanthemum morifolium ‘Boju’ (C. morifolium); however, the molecular regulatory network governing flower development remains largely elusive. Flower samples were collected at four stages, namely budding (BD), bud breaking (BB), early blooming (EB), and full blooming (FB), for omics analysis. We revealed distinct transcriptional regulation patterns at these four stages of the flower from the perspective of differentially expressed unigenes (DEGs). There are 152 DEGs shared among the three comparative groups (BD vs. BB, BB vs EB, EB vs FB), wherein the expression of 44 DEGs (including AtADT6, MDL3, and ROMT) continues to be upregulated, and 85 DEGs (including CYP81E, TPS-Cin-1, and TPS-Cin-2) showed persistent downregulation with flower development. Flavonoid-targeted metabolomics identified 118 differentially abundant metabolites (DAMs) in the FB group compared to the BD stage; the top three upregulated and downregulated metabolites are Cyanidin-3-O-(6″-O-malonyl)glucoside-5-O-glucoside, Luteolin-7-O-(6″-caffeoyl)rhamnoside, Kaempferol-3-O-(6″-p-coumaroyl)glucoside and Chrysoeriol-6,8-di-C-glucoside-7-O-glucoside, Kaempferol, Kaempferol-3,7-O-dirhamnoside, respectively. These DAMs were predominantly enriched in “flavonoid biosynthesis”, “isoflavonoid biosynthesis”, and “flavone and flavonol biosynthesis” pathways. AtADT6, MDL3, ROMT, CYP81E, TPS-Cin-1, and TPS-Cin-2 were correlated with kaempferol. Our findings provide a new idea for interfering with flavonoid production, especially kaempferol, in flowers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Horticultural Crop Germplasm Innovation and Utilization (Co-Construction by Ministry and Province), Institute of Horticulture, Anhui Academy of Agricultural Sciences, Hefei 230001, China.
Förderung
- China Agriculture Research System
- Joint Research Center for Chinese Herbal Medicine of Anhui of IHM Project
Zitieren
APA
Chu, Z., Xiong, R., Peng, X., Cui, G., Dong, L., & Li, W. (2024). Delineating Molecular Regulatory of Flavonoids Indicated by Transcriptomic and Metabolomics Analysis during Flower Development in Chrysanthemum morifolium ‘Boju’. International Journal of Molecular Sciences, 25(19), 10261. https://doi.org/10.3390/ijms251910261
Vancouver
Chu Z, Xiong R, Peng X, Cui G, Dong L, Li W. Delineating Molecular Regulatory of Flavonoids Indicated by Transcriptomic and Metabolomics Analysis during Flower Development in Chrysanthemum morifolium ‘Boju’. International Journal of Molecular Sciences. 2024;25(19):10261. doi:10.3390/ijms251910261
BibTeX
@article{Chu2024,
author = {Chu, Zhuannan and Xiong, Rui and Peng, Xingxing and Cui, Guangsheng and Dong, Ling and Li, Weiwen},
title = {Delineating Molecular Regulatory of Flavonoids Indicated by Transcriptomic and Metabolomics Analysis during Flower Development in Chrysanthemum morifolium ‘Boju’},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {19},
pages = {10261},
doi = {10.3390/ijms251910261}
}
EUVIMED